Citation Impact

Citing Papers

The Clinical Spectrum of Aspergillosis—Part 1: Epidemiology, Pathogenicity, Infection in Animals and Immunology of Aspergillus
1980
The Clinical Spectrum of Aspergillosis–Part 2: Classification and Description of Saprophytic, Allergic, and Invasive Variants of Human Disease
1980
Monitoring Sedation Status Over Time in ICU Patients
2003 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.
1979
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults
2012
Bronchial elastic fibers in normal subjects and asthmatic patients.
1996
Reproducibility of allergen-induced early and late asthmatic responses
1995
Allergic bronchopulmonary aspergillosis
2002
Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial
2008 Standout
Aspergillus in the lung: diverse and coincident forms
2003
The pathology of fungal infection and colonization in patients with cystic fibrosis
1989
High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease
2011
Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis
1992
Allergic Bronchopulmonary Aspergillosis in the Asthma Clinic
2000
IgE and mast cells in allergic disease
2012 Standout
Inhibition of phagocyte migration and spreading by spore diffusates ofAspergillus fumigatus
1987
Comparison of narrow section computed tomography and plain chest radiography in chronic allergic bronchopulmonary aspergillosis
1987
Allergic Rhizomucor sinusitis
1992
Aspergillus fumigatus specific IgE and IgG antibodies for diagnosis of Aspergillus‐related lung diseases
1991
Mechanisms of Improvement in Exercise Capacity Using a Rollator in Patients With COPD
2004
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Asthma: a disease remodeling the airways
1992
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents
1992 Standout
Diagnostic criteria for allergic fungal sinusitis
1995
Tolerance of normal tissue to therapeutic irradiation
1991 Standout
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management
2015
The Clinical Spectrum of Pulmonary Aspergillosis
2002
Interpretative strategies for lung function tests
2005 Standout
Gender difference in smoking effects on adult pulmonary function
1994
Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial
2013
Mast Cells in Lung Inflammation
2011
Magnesium Sulfate Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease Exacerbation
2012
Large Lungs after Childhood Asthma: A Case-Control Study
1993
Differences in the expression of the cardiopulmonary alterations associated with anti-immunoglobulin E-induced or active anaphylaxis in mast cell-deficient and normal mice. Mast cells are not required for the cardiopulmonary changes associated with certain fatal anaphylactic responses.
1991
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Asthma and Wheezing in the First Six Years of Life
1995 Standout
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice.
1989
Idiopathic Pulmonary Fibrosis
2001 Standout
The epidemiological importance of intraindividual changes in objective pulmonary responses
1987
Fleischner Society: Glossary of Terms for Thoracic Imaging
2008 Standout
Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis
1990
Pulmonary Considerations of Organ Transplantation: Part I
1991
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
1999 Standout
Internet-Based Home Asthma Telemonitoring
2000
A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
2000
Immunity to fungal infections
2011 Standout
Comparison of PEFR and FEV1 in Patients with Varying Degrees of Airway Obstruction
1989
Systemic effects of chronic obstructive pulmonary disease
2003
Allergenic cross‐reactivity of yeasts
1988
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Mast cells in the development of adaptive immune responses
2005 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: Prevalence and percentage of positive tests in the employed diagnostic criteria
2000
Evidence-Based Guidelines for Weaning and Discontinuing Ventilatory Support
2001
Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease
2008
Antibody testing in aspergillosis—quo vadis?
2015
Practice Guidelines for Diseases Caused by Aspergillus
2000
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Epidemiology of Obstructive Sleep Apnea
2002 Standout
Guidelines for Methacholine and Exercise Challenge Testing—1999
2000 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Idiopathic Pulmonary Fibrosis
1998 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Increased Levels of Elastase and α 1 -Antitrypsin in Sputum of Asthmatic Patients
1998
Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature
1986 StandoutNobel
Physiological and Radiographic Assessment During the Development of Pulmonary Radiation Fibrosis
1977
Multifocal pulmonary aspergillomas: case series and review
2012
Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis
1977
Reversibility of pulmonary function abnormalities in smokers
1975
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
Pulmonary Function During Clinical Remission of Asthma How Reversible is Asthma?*
1973
Antibodies to “Alcalase” after Industrial Exposure
1971 StandoutNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
Health Effects of Fine Particulate Air Pollution: Lines that Connect
2006 Standout
Allergie Bronchopulmonary Aspergillosis: A Review
1992
Suppression of host defences by Aspergillus fumigatus.
1987
Multi-breath and single breath helium dilution lung volumes as a test of airway obstruction
1990
Zygomycetes in Human Disease
2000 Standout
ALLERGIC REACTIONS OF THE LUNGS TO ENZYMES OF BACILLUS SUBTILIS
1969
Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.
1982
Measurements of responsiveness in bronchoprovocation testing
1979
Fungal allergy in asthma–state of the art and research needs
2014
Asthma and irreversible airflow obstruction.
1984
Allergic Bronchopulmonary Aspergillosis
1987
Complement Activation during Cardiopulmonary Bypass
1981 Standout
Lung volumes and forced ventilatory flows
1993 Standout
Magnesium Sulfate in Exacerbations of Chronic Obstructive Pulmonary Disease
1995
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Inhibition of lymphocyte-mediated cytolysis by 2-fluoroadenosine-
1978 StandoutNobel
Role of lung volumes in sleep apnoea-related oxygen desaturation
1989
Vision assessment using the NIH Toolbox
2013 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis
1977
Activation of guanylate cyclase from rat liver and other tissues by sodium azide.
1975 StandoutNobel
Ecological Momentary Assessment
2007 Standout
Smoking, changes in smoking habits, and rate of decline in FEV1: new insight into gender differences
1994
2-Fluoroadenosine 3':5'-monophosphate. A metabolite of 2-fluoroadenosine in mouse cytotoxic lymphocytes.
1976 StandoutNobel
Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review
2014
Airway closure and pregnancy
1977
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
1991
Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine
1987
Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence‐based review and recommendations
2014
Inhibition of lymphocyte-mediated cytolysis by adenosine analogs
1978 StandoutNobel
Aspergillus fumigatusand Aspergillosis
1999 Standout
6-Minute walk test in patients with COPD: clinical applications in pulmonary rehabilitation
2007
EFFECT OF DISODIUM CROMOGLYCATE ON SEASONAL ALLERGIC RHINITIS
1971
The UCLA Population Studies of Chronic Obstructive Respiratory Disease
1980
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Idiopathic Pulmonary Fibrosis
1976
Allergic Aspergillus sinusitis
1985
The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis
1978
Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia
1997
Immunologic and Nonimmunologic Generation of Superoxide from Mast Cells and Basophils
1978
Secretory products of macrophages.
1987 Standout
Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis.
1978
Clinical and immunological responses to enzymes of Bacillus subtilis in factory workers and consumers
1973
Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction.
1992
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria
2013
Changes in Measured Spirometric Indices
1981
Treatment of seasonal allergic rhinitis with 2% sodium cromoglycate (BP) solution
1973
Lung Infections Associated with Cystic Fibrosis
2002 Standout
PULMONARY DISEASE DUE TO INHALATION OF DERIVATIVES OF BACILLUS SUBTILIS CONTAINING PROTEOLYTIC ENZYME
1969
Hidden Killers: Human Fungal Infections
2012 Standout
IgE, IgA and IgG antibodies and delayed skin response towards Candida albicans antigens in atopies with and without saprophytic growth
1990
Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells.
1987
Immunodiagnosis of aspergillosis
1991
Complement and Leukocyte-Mediated Pulmonary Dysfunction in Hemodialysis
1977
Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis.
1980 Standout
Allergic Bronchopulmonary Aspergillosis: Staging as an Aid to Management
1982
Immunopathology of allergic lung disease*
1973
Disodium Cromoglycate, an Inhibitor of Mast Cell Degranulation and Histamine Release induced by Phospholipase A
1969 Nature
Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis.
1978
Heat shock protein 88 and Aspergillus infection
1991
Disodium cromoglycate in ragweed-allergic rhinitis
1976
Cyclic nucleotides and modulation of effector systems of inflammation
1974

Works of D.S. McCarthy being referenced

Computer analysis of the single-breath nitrogen washout curve.
1976
Closing Volume in Asymptomatic Asthma 1
1973
INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTS
1968
Measurement of “closing volume” as a simple and sensitive test for early detection of small airway disease
1972
Relationship between the single-breath N test and age, sex, and smoking habit in three North American cities.
1979
Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects.
1975
Effect of modification of the smoking habit on lung function.
1976
Regional ventilation-perfusion and hypoxia in cryptogenic fibrosing alveolitis.
1973
Lung elastic recoil and reduced airflow in clinically stable asthma.
1980
Allergic broncho‐pulmonary aspergillosis
1971
Pulmonary aspergilloma—clinical immunology
1973
Postural relief of dyspnoea in severe chronic airflow limitation: relationship to respiratory muscle strength.
1983
Hypomagnesemia and respiratory muscle power.
1984
Allergic broncho‐pulmonary aspergillosis Clinical immunology: (2) Skin, nasal and bronchial tests
1971
The radiological appearances in allergic broncho-pulmonary aspergillosis
1970
Candida albicans precipitins in respiratory disease in man
1968
Regional lung function in patients with hepatic cirrhosis
1971
Bronchiectasis in Allergic Bronchopulmonary Aspergillosis
1968
Rankless by CCL
2026